ELQ-300, a bioavailable antimalarial agent, is a potent inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1).
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Complex III of the mitochondrial electron transport chain, also known as the cytochrome bc1 complex (cyt bc1), is a validated target for multistage antimalarial therapy. ELQ-300, a potent and orally bioavailable antimalarial agent, acts as an inhibitor of the reductive (Qi) site of cyt bc1. ELQ-300 sensitized P. falciparum Dd2, Tm90-C2B, and D1 strains with IC50s of 6.6, 4.6 and 160 nM, respectively. Compared to the 6-halogen compounds ELQ-314, ELQ-296, and ELQ-339, ELQ-300 demonstrated both increased potency and more pronounced D1 cross-resistance, which correlated with halogen size[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.10mL 0.42mL 0.21mL |
10.51mL 2.10mL 1.05mL |
21.02mL 4.20mL 2.10mL |
CAS号 | 1354745-52-0 |
分子式 | C24H17ClF3NO4 |
分子量 | 475.844 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
DMSO: 15 mg/mL(31.52 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |